Overview
AVXL market data
Price History
AVXL price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.54 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.19 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.26 – $10.98 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $300.3M · P/B 8.06.
Company News
8-K filing — ANAVEX LIFE SCIENCES CORP. (AVXL)SEC EDGAR · Aug 11, 2026, 9:00 PM
Anavex Life Sciences Urges Stockholders To Reject Attempt By PVG Asset Management And Patrick S. Adams To Acquire Control Of The CompanyBenzinga · Aug 3, 2026, 12:07 PM
Anavex Life Sciences Q2 EPS $(0.06) Beats $(0.08) EstimateBenzinga · Jul 30, 2026, 12:41 PM
Anavex Life Sciences Reports Preliminary Q2 Net Loss Of $0.06 Per Share vs. $0.13 A Year Ago; $127.4M Cash Funds Operations Into Mid-To-Late Fiscal 2028Benzinga · Jul 30, 2026, 12:06 PM
Anavex Life Sciences Receives Expected Delinquency Notification From NasdaqBenzinga · May 22, 2026, 12:10 PM